Antigen-Specific Tolerogenic and Immunomodulatory Strategies for the Treatment of Autoimmune Arthritis
- 31 December 2008
- journal article
- review article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 38 (3), 195-207
- https://doi.org/10.1016/j.semarthrit.2007.10.002
Abstract
No abstract availableKeywords
This publication has 145 references indexed in Scilit:
- Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse modelArthritis & Rheumatism, 2007
- Molecular mechanisms for adaptive tolerance and other T cell anergy modelsSeminars in Immunology, 2007
- TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1Nature Medicine, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007
- Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of LupusImmunity, 2006
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006
- Antigen-Specific Therapies in Multiple Sclerosis: Going Beyond Proteins and PeptidesInternational Reviews of Immunology, 2005
- CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritisHuman Immunology, 2004
- Gene therapy for autoimmune diseases: quo vadis?Nature Reviews Immunology, 2004
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003